If you think speaking English is enough to succeed in Japan, think again.
Many European and North American pharma executives—especially those at CDMOs or mid‑sized firms—enter Japan with confidence. They bring English‑speaking reps, polished slides, and strong tech. Yet despite initial enthusiasm, meetings stall, deals fade, and progress grinds to a halt.
Welcome to the invisible wall—and this isn’t just observation. It’s from someone who grew up on the other side.
✳️ A Personal Note from Gifu, Japan
I was born and raised in Gifu, a quiet region in central Japan, and went through the public school system until age 18. Like most of my peers, I studied English for six years—but it was almost entirely grammar, reading, and writing. Speaking and listening were virtually absent from the curriculum. By the time we graduated, we could pass written exams—but struggled to speak confidently in real-world situations.
At 18, I moved to the United States to attend university. That experience broadened my worldview and gave me a more Western perspective on communication and business. After graduating, I returned to Japan and joined Pfizer Japan as a pharmaceutical development scientist. But a few years later, I took a leap: I joined a Swiss pharmaceutical company, and eventually worked for over a decade in Switzerland and Germany at global CDMOs.
During that time, I led formulation and development projects, including sustained-release injectables, and managed several co-development programs with Japanese pharma companies. My role often placed me between R&D and Business Development—acting as a bilingual, bicultural bridge between scientists, regulators, and clients.
This unique journey—growing up in Japan, studying in the U.S., and working in Europe—taught me that language is just the beginning. Real success in Japan comes from understanding the unspoken expectations, the cultural tempo, and the business logic behind the words.
Japan in 2024: Still Low in English Proficiency 📉
This isn’t just anecdotal.
In the EF English Proficiency Index 2024, Japan ranked 92nd out of 116 countries, with a score of 454, placing it in the Low proficiency category. Despite over a decade of English education in schools, many Japanese professionals—especially those in decision-making roles—struggle with real-time English communication.
To put this into context, let’s compare with other markets often viewed by Europeans as communication-challenging:
- China: Ranked 91st, score 455 (Low proficiency)
- Saudi Arabia: Ranked 105th, score 417 (Low proficiency)
- South Korea: Ranked 50th, score 523 (Moderate proficiency)
While South Korea performs slightly better, European business executives consistently report that Japan remains one of the most difficult countries in Asia to engage with meaningfully in English—due not only to low proficiency, but to deep-rooted cultural factors that affect how (and if) communication occurs.
What makes Japan uniquely challenging is that language is only the first barrier. Even when English is understood, unspoken social norms, rigid hierarchies, and a fear of making mistakes often prevent open dialogue. Meetings may appear smooth, but misunderstandings are frequently buried beneath surface-level politeness—only to emerge after the meeting is over, or not at all.
The Real Barrier: Psychological Distance, Not Just Language
Even when Japanese professionals know English, many hesitate to speak it. The barrier is more cultural than linguistic:
- In Japanese business culture, meetings are ceremonial and consensus‑oriented, not debate‑based.
- Many Japanese do not express “no” directly, nor ask pointed questions in the meeting itself. Clarifications often come after the meeting—if they come at all.
In multi‑national meetings I’ve observed, things appear smooth on the surface. But afterward…
“I wasn’t really sure what they meant.”
“I didn’t feel comfortable interrupting.”
“That wasn’t the time to say no.”
This reflects a psychological barrier rooted in avoiding mistakes and maintaining harmony—a mindset very different from European meeting norms.
Why English‑Only Isn’t Enough—and a Translator Alone Won’t Fix It
Some foreign companies bring translators, but that’s often insufficient. Without cultural fluency, interpreters may translate words—but not intentions, context, or internal corporate dynamics.
Consider a German CDMO client: despite bilingual translation support, they couldn’t progress meetings. Once they partnered with culturally fluent Japanese BD professionals, discussions began moving toward real outcomes.
Psychological trust, not just language accuracy, makes the difference.
Japan’s Homogeneous Context: Where the Barrier Begins
Most decision‑makers in Japanese pharma are Japanese by ethnicity and education. Many have never lived abroad or worked with foreign partners. Even open-minded individuals often internalize misunderstandings rather than voice them.
Unlike Latin and Southern European cultures—where speaking up and accepting mistakes is normal—many Japanese feel ashamed of saying something imperfect, even if it’s helpful.
This contributes to silence in meetings—and difficulty progressing deals.
A Simple Tactic: Signal Japanese-Speaking Local Support Early
A practical strategy I’ve seen work with European CDMOs:
Mention early that a Japanese-speaking representative will be involved.
That small detail signals commitment, reduces anxiety, and improves openness. I’ve seen a counterpart go from hesitant to engaged simply by knowing a Japanese liaison would manage communication.
Why WeBD.Tokyo Is Your Key Bridge
At WeBD.Tokyo, we don’t just translate. We represent, interpret, and execute—as part of your extended team in Japan.
What sets us apart is not only our cultural fluency, but also our deep technical and operational understanding of the CDMO business.
Our founder previously led pharmaceutical development at a European CDMO, managing sustained-release injectable projects and co-development partnerships with Japanese pharma clients. He understands not just the business—but the bench-level challenges, CMC timelines, and regulatory expectations that come with formulation development and tech transfer.
This dual perspective—business and technical, Western and Japanese—allows WeBD.Tokyo to:
- Ask the right questions in the right way
- Translate scientific intent into actionable proposals
- Build trust with Japanese QA/QC, regulatory, and development teams
- Accelerate collaborations by navigating both cultural and technical roadblocks
We’ve helped European CDMOs:
- Secure GMP-aligned Japanese manufacturing partnerships
- Translate technical proposals into PMDA-compliant strategies
- Bridge the “last mile” from handshake to signed agreement
Japan doesn’t reward those who speak English—it rewards those who speak Japan. And that includes both its language and its science.
Final Thoughts: Respect the Wall—Then Build the Bridge
The invisible wall may be real—but it’s climbable.
With a partner who understands both sides, you don’t just navigate—it becomes your bridge to long‑term success in Japan.
If you’re serious about market entry, let’s build that bridge together.